Costa Rica vs Sur: New cases tested for RR-/MDR-TB
Costa Rica
100.0%
in 2024
Sur
97.0%
in 2024
Costa Rica rank
1st
Sur rank
2nd
New cases tested for RR-/MDR-TB over time
- Costa Rica
- Sur
How they compare
Costa Rica currently reports 100.0% against 97.0% in Sur, a difference of 3.0%.
The two have swapped places 5 times across 15 shared years of data; in 2005 it was Sur ahead.
Costa Rica ranks 1st and Sur ranks 2nd of 192 countries.
Sur has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Costa Rica | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.2% | 48.0% | 47.8% | Sur |
| 2010s | 52.1% | 58.1% | 6.0% | Sur |
| 2020s | 70.8% | 96.8% | 26.0% | Sur |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Costa Rica or Sur?
- Costa Rica, at 100.0% against 97.0% in Sur as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Costa Rica and Sur?
- 3.0%, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and Sur?
- 15 years are reported by both, from 2005 to 2024.
- How do Costa Rica and Sur rank globally for new cases tested for rr-/mdr-tb?
- Costa Rica ranks 1st and Sur ranks 2nd of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.